the principal investigator and leader designation was changed from Ricordi (UofM) to Veltmeyer (TSOI) for the P3clinical trial on ARDS . the U of M is out . the cells will be coming in the future from Allogen, as TSOI progresses on w/ P3 TSOI clinical trial.
Solid PR .
Gotta have the cells to do the clinical trial . gotta get a lot of patients registered and vetted before the cells are delivered to the clinical trial .
News 
Market Data 
Discover 
